Edison Scientific teams with Metsera-backed founders to scale biotech ventures with AI agents
Edison Scientific, spun off from FutureHouse with roughly $70 million in funding, is being tapped by the Metsera-backed team and Population Health Partners to scale the creation of new biotech companies using AI agents capable of autonomous reasoning, reflecting pharma’s growing interest in AI-driven drug discovery.
